Project Grant HT94252410672
Award Date
9/15/24
Completion Date
9/14/27
Dollars Obligated
$975K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,309,471 Project Grant to New York University (NYU) School of Medicine to conduct research on the "Genomic and Molecular Imprints of Carcinogenic Benzene Exposure." The project, which spans from September 2024 to September 2027, will investigate the molecular mechanisms and genetic markers associated with benzene exposure and its relationship to cancer development. As a...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $325,947 Project Grant to New York University (NYU) School of Medicine on September 15, 2024. The grant supports a 3-year research project titled "Genomic and Molecular Imprints of Carcinogenic Benzene Exposure." This funding enables NYU's research team to investigate the genomic and molecular impacts of benzene exposure, with the goal of advancing scientific...
The U.S. Department of the Army Medical Command awarded a $2,013,978.00 Project Grant to New York University (NYU) School of Medicine on July 1, 2025 under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant funds research aimed at "Targeting RAGE After Particulate Matter Exposure: Metabolic Dysregulation and Disease Mitigation" over a performance period ending on June 30, 2028. As a leading academic medical center, NYU School of Medicine will...
The federal Project Grant award of $680,757.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research by New York University School of Medicine to investigate the impact of particulate matter exposure on metabolic dysregulation and disease mitigation. The award, effective July 1, 2025 through June 30, 2028, will fund advanced biomedical research initiatives focused on transforming healthcare for military service...
New York University School of Medicine was awarded a $762,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project titled "BEYOND VEXAS AND UBA1: IDENTIFICATION OF NOVEL DRIVERS OF MDS AUTOIMMUNE SYNDROMES" from June 15, 2023 through June 14, 2026. The grant supports research to identify novel drivers of myelodysplastic syndromes, blood disorders that can progress...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $254,153.00 in funding to New York University School of Medicine to conduct research on the relationship between microplastics and prostate cancer. The project will run from March 1, 2025 to February 28, 2027. As a leading academic medical center and research institution, New York University School of Medicine will leverage its...
New York University School of Medicine was awarded a $911,777 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into Mitochondrial Dynamics as a Therapy Target in Myelodysplastic Syndromes. Through September 2025, NYU School of Medicine researchers will investigate medical solutions for blood cancers like MDS by exploring mitochondrial functions and their potential as...
The Department of the Army Medical Command awarded New York University School of Medicine a $1,186,500 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2024 to understand the transition from nevi to melanoma occurring within the skin epidermis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...
The New York University will receive $936,199 under a Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Under this three-year award beginning September 2022, New York University researchers will investigate receptors in endosomes that mediate chronic pain associated with trauma,...
This $2,660,756 federal Project Grant award from the Department of Defense's Defense Health Agency supports research on "GENOMIC AND IMMUNOMIC MECHANISMS OF RESISTANCE DURING DARATUMUMAB POST STEM CELL TRANSPLANTATION IN PATIENTS WITH POOR-RISK T CELL LYMPHOBLASTIC LYMPHOMA LEUKEMIA". It is funded under the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research to address health conditions affecting service members and veterans. The...